Vaccine | Immunizations |
---|---|
Comirnaty | 2.34M |
Vaxzevria | 478.29K |
COVID-19 Vaccine Janssen | 465.56K |
COVID-19 Vaccine Moderna | 413.91K |
Hexacima | 48 |
SYNFLORIX | 41 |
Infanrix Hexa | 22 |
ROTARIX | 11 |
Pentaxim | 3 |
M-M-RVAXPRO | 3 |
TETADIF | 3 |
Boostrix | 2 |
Adacel | 2 |
PPD Tuberculin Mammalian | 1 |
Prevenar 13 | 1 |
Gardasil | 1 |
Engerix B | 1 |
Priorix | 1 |
RotaTeq | 1 |
BCG vaccine, freeze-dried | 1 |
Age | Gender | Immunized Patients |
---|---|---|
0-3 | Female | 43 |
0-3 | Male | 112 |
4-7 | Female | 69 |
4-7 | Male | 76 |
8-11 | Female | 150 |
8-11 | Male | 173 |
12-15 | Female | 5.51K |
12-15 | Male | 5.84K |
16-19 | Female | 18.80K |
16-19 | Male | 19.31K |
20-23 | Female | 33.55K |
20-23 | Male | 34.00K |
24-27 | Female | 33.36K |
24-27 | Male | 36.15K |
28-31 | Female | 43.77K |
28-31 | Male | 47.13K |
32-35 | Female | 56.35K |
32-35 | Male | 59.84K |
36-39 | Female | 60.48K |
36-39 | Male | 63.76K |
40-43 | Female | 68.60K |
40-43 | Male | 71.23K |
44-47 | Female | 78.58K |
44-47 | Male | 79.91K |
48-51 | Female | 74.43K |
48-51 | Male | 74.26K |
52-55 | Female | 71.86K |
52-55 | Male | 70.35K |
56-59 | Female | 72.67K |
56-59 | Male | 68.62K |
60-63 | Female | 76.72K |
60-63 | Male | 70.21K |
64-67 | Female | 80.18K |
64-67 | Male | 69.91K |
68-71 | Female | 79.74K |
68-71 | Male | 65.35K |
72-75 | Female | 70.78K |
72-75 | Male | 54.85K |
76-79 | Female | 45.87K |
76-79 | Male | 34.20K |
80-83 | Female | 28.29K |
80-83 | Male | 20.40K |
84-87 | Female | 15.37K |
84-87 | Male | 11.10K |
88-91 | Female | 5.38K |
88-91 | Male | 4.09K |
92-95 | Female | 1.17K |
92-95 | Male | 905 |
96-99 | Female | 179 |
96-99 | Male | 103 |
100-103 | Female | 13 |
100-103 | Male | 8 |